Education loan book growth to halve amid US visa curbs
'Policy uncertainties in the US, combined with measures including reduced visa appointments and the proposed elimination of Optional Practical Training norms have culled newer loan originations. This has led to around 30% decline in total disbursements to that geography last fiscal,' said Malvika Bhotika, Director at Crisil Ratings.
According to the ratings agency, education loans had been the fastest-growing asset class for NBFCs in recent years, with assets under management (AUM) rising by over 50% annually.
However, Crisil expects this growth to moderate to around 25% in the current fiscal, down from 48% last year and 77% the year before. The AUM is projected to reach ₹80,000 crore by March 2026, up from ₹64,000 crore in FY25.
The slowdown has been attributed to a sharp decline in loan disbursements to the US — traditionally the largest destination for Indian students — as the country reduces visa appointments and considers scrapping the Optional Practical Training (OPT) programme for international students.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
5-year-old girl needs her second heart surgery!
Donate For Health
Donate Now
Undo
Disbursements to Canada, the second-largest market, also declined due to stricter student visa rules, including higher financial requirements and a cap on permits. As a result, overall education loan disbursements rose just 8% in FY25, a sharp fall from the 50% growth seen in FY24.
To counter the US-led slowdown, NBFCs are now diversifying into alternative geographies such as the UK, Germany, Ireland and other smaller nations.
Disbursements to these destinations have doubled, with their combined share in total education loan disbursals rising from 25% in FY24 to nearly 50% in FY25. However, this diversification is unlikely to fully offset the drop in US-bound disbursals.
The US still accounted for 50% of total education loan portfolios as of March 2025, down from 53% a year earlier, and this share is expected to decline further in the coming years.
NBFCs are also exploring new product adjacencies including domestic student loans, school funding, and loans for skill development and coaching. While these segments involve lower ticket sizes and are unlikely to materially impact AUM, they may offer portfolio stability during global disruptions.
Asset quality in the sector remains strong for now, with gross non-performing assets (NPAs) at 0.1% as of March 31, 2025.
Even after adjusting for the principal moratorium — which covers around 85% of the loan book — gross NPAs stood at ~0.7%.
'Despite the global developments, NBFCs have maintained healthy asset quality so far,' said Sonica Gupta, Associate Director at Crisil Ratings. 'However, high growth in the past few years and estimated ~15% of the portfolio coming out of contractual moratorium this fiscal pose some asset quality risks.'
The report emphasizes that NBFCs' ability to scale newer segments while maintaining quality, and to adapt to changing student preferences and international policies, will be critical for sustaining growth in the education loan segment. The analysis is based on NBFCs rated by Crisil, which represent over 90% of the industry's total AUM.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fibre2Fashion
28 minutes ago
- Fibre2Fashion
Global trade deterioration eases in Jun: S&P Global PMI data
Global trade conditions continued to deteriorate at the end of the second quarter (Q2) this year and the rate of decline eased for a second successive month and was only marginal, worldwide purchasing managers' index (PMI) surveys compiled by S&P Global Market Intelligence indicate. The seasonally-adjusted global PMI new export orders index, sponsored by JPMorgan, rose to 49.1 in June, up from 48 in May. Posting below the 50 neutral mark for a third successive month, the latest data indicated another contraction in trade activity. While the global manufacturing sector's export contraction persisted in June, the rate of decline softened to the slowest in the current three-month sequence, Jingyi Pan, economics associate director of operations-IMPG at S&P Global Market Intelligence, wrote on the company's website. Global trade conditions continued to deteriorate at the end Q2 2025 and the drop rate eased for a second month in a row and was only marginal, S&P Global Market Intelligence said. The number of top ten trading economies reporting higher goods exports was just two at the end of Q2: India and the US. India continued to lead export growth by a wide margin with a further acceleration in the growth rate. Further front-loading of goods orders ahead of the higher US tariffs deadline (July 9) supported the slower pace of deterioration in goods trade. This was evident with global production growth resuming at the quickest pace since February as manufacturers worked through existing orders in the lead up to the anticipated deadline. Additionally, stock building was again elevated among US manufacturers, though subdued across the rest of the world. Sentiment data also pointed to muted optimism regarding growth in the year ahead. Business confidence stayed below the series average reflecting some apprehension regarding the outlook, especially surrounding trade. Mentions of 'uncertainty' among goods producers were also elevated at multiples of the historical average, albeit down further from the peak in April. Even if trade uncertainty should ease in the coming months - the hangover from front-loading of goods orders in the first half of 2025 may lead to more subdued trade conditions in the coming months, Pan observed. The contraction in export business was broad-based in June, with the rates of reduction softening across both developed and emerging markets. After recording a steeper rate of export contraction for the first time in three years, emerging markets export business declined marginally at the end of the second quarter, he added. The number of top ten trading economies reporting higher goods exports remained at just two at the end of Q2 2025: India and the United States. India continued to lead export growth by a wide margin with a further acceleration in the rate of expansion. Demand strengthened from across the globe, especially from the United States. This led to Indian manufacturing exports rising at the third-fastest pace since data collection began for the series in March 2005. Goods export orders growth also accelerated in the United States to the quickest pace in just over a year despite trade policy impact. Modest slowdown in goods trade activity was recorded in Japan and South Korea, while only marginal declines were reported in the European Union and China. Fibre2Fashion News Desk (DS)
Hans India
33 minutes ago
- Hans India
India's GDP growth intact amid global uncertainty
New Delhi: India's economic growth remains on track amid global uncertainties, with an improvement in high frequency indicators for both services and manufacturing, and consumption picking up momentum during Q1/FY26 versus Q4 of FY25, according to a Bank of Baroda (BoB) report released on Friday. High frequency data available for the first quarter (Q1) so far shows that consumption demand appears to be improving compared with the last quarter. This is reflective in the rise in steel consumption growth, increase in electronic imports, and higher central government revenue spending, theBoB report states. Services indicators are also showing a pickup in activity, as can be seen in case of services PMI, vehicle registrations, diesel consumption, revenue collection of states and e-way bill generations. However, some strains can be seen in performance of 2-wheeler sales, and moderation in consumer durables and FMCG output. However, domestic inflation remains in favour, which hints at softer monetary policy which would spur growth, the report adds. It also highlights that monsoon activity is healthy at 15 per cent above long period average so far (as of July 9) which is expected to give a fillip to the agricultural sector. The Central government finances are on a solid footing with the fiscal deficit ratio eased to 4.5 per cent as of May 2025 from 4.6 per cent as of April 2025, the report observes. The report is also positive on the outlook for the rupee. It stated that the rupee depreciated marginally by 0.2 per cent in June after depreciating by 1.3 per cent in May. Easing geo-political tensions and a weaker dollar, led to range-bound trading in the domestic currency in the later part of the month. 'In July, the rupee is trading with an appreciating bias despite lingering concerns over US tariff policies. We expect this trend to continue. Investors remain hopeful of the successful completion of India-US trade deal before the August 1 deadline, which will lend further support to the rupee, the report said.
News18
an hour ago
- News18
'Pulp Fiction? Not Quite': How Indian Oranges Are Powering A French Medicine To Treat Varicose Veins
'We are proud that the oranges grown in Indian soil are now an integral part of a medicine used by millions across the world," Aurelien Breton, managing director, Servier India, told News18. 'We procure oranges from Maharashtra, Telangana, Andhra Pradesh, MP, and Rajasthan currently." According to IQVIA data, Daflon's 500mg and 1000mg stand at a value of Rs 61 crore as per moving annual turnover, May 2025, ranking 2nd in the varicose therapy market. The average number of patients treated in a month is 1.2 lakhs. The citrus supply chain The Indian-sourced oranges are first processed locally—cleaned, dried, and converted into powder form. This citrus powder is then exported to Servier's manufacturing headquarters in France, where it undergoes sophisticated processing to extract the active pharmaceutical ingredients (APIs). Interestingly, those APIs are then re-imported back to India, where the final formulation of Daflon is completed for domestic distribution. This circular, transcontinental journey of a single orange—from a farm in Nagpur to a lab in northern France and back to a pharmacy shelf in Delhi—highlights the globalisation of pharmaceutical supply chains and India's growing importance as a trusted sourcing and manufacturing hub. The move wasn't just about logistics or cost-efficiency. According to Breton, Indian oranges matched the quality standards required for flavonoid extraction. 'We achieved 100% reliance on local Indian oranges through our Indian supply chain with effect from the financial year 2021." Indian oranges matched the former Spanish and Mexican counterparts. '2000 metric tons of small oranges were procured in the financial year 2023-24. We work with aggregators and farmers in multiple states in India," said Breton. Company set to bring precision cancer medicine Servier Pharma is set to bring precision cancer treatments to India. 'Unlike traditional chemotherapy, these therapies act on specific genetic mutations that are responsible for causing the cancer," Breton said. Out of three novel drugs coming into the Indian market, the first drug, Ivosidenib, targets a mutated protein known as isocitrate dehydrogenase 1 (IDH1), which is found in a subset of patients with cholangiocarcinoma (a type of biliary tract cancer) and acute myeloid leukemia (a form of blood cancer). 'Epidemiological data show a high prevalence of biliary tract cancers along the Ganga River basin, supporting the need for this targeted option, which can significantly delay disease progression. In clinical trials, Ivosidenib has demonstrated more than a threefold improvement in survival for AML (blood cancer) patients." The drug was officially launched in India in June 2025.
